The Biologics Market Outlook And Analysis By Product (Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, Gene Therapy, Others), By Disease Indication (Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, Cancer, Diabetes, Others), By Manufacturing (In-house, Sourced) - Forecast to 2030
The global biologics market is predicted to touch USD 425.5 billion at an 7.6% CAGR between 2023 -...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian